2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee
FDA Comment Number : EC18
Submitter : Dr. David Healy Date & Time: 09/02/2004 05:09:23
Organization : Cardiff University
Health Professional
Category :
Issue Areas/Comments
In recent weeks, Pfizer have posted on the FDA website in connection with a forthcoming PDAC hearing an ad hominem attack on me. This was apparently cleared before posting by FDA's chief counsel,Daniel Troy, who has had a prior close working relationship with Pfizer. The attached material constitutes a preliminary response.